Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atigun Capital Partners is a specialized investment management firm focused on the healthcare and life sciences sectors. Based in New York, the firm utilizes a fundamental, research-intensive approach to identify investment opportunities across the biotechnology, pharmaceutical, and medical technology landscapes. Atigun invests in both public and private companies, prioritizing those with innovative platforms or therapies that address significant unmet medical needs. The firm was founded by William Slattery, a veteran healthcare investor, and maintains a portfolio designed to capture value from clinical and regulatory milestones. Atigun's investment strategy often involves deep-dive analysis of clinical data and therapeutic markets to drive long-term returns.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atigun Capital Partners.